top of page
UT.jpg

IN THE STATES

UTAH

The economic footprint of the biopharmaceutical industry can be measured by traditional indicators of employment and output, and its impact on the vendors, large and small, that provide services or supplies to America's biopharmaceutical research companies. The data below illustrates jobs, economic impact and clinical trial data for the industry as a whole, and vendor/supplier data from 15 major biopharmaceutical companies regarding their business relationships and total expenditures paid to vendors in Utah in 2022.

UT.png

Economic
Output

$23.6B

Direct Jobs Supported by the Industry

16,508

Total Jobs Supported

81,474

State Total Vendor Relationships

335

State Total Vendor Spending

$192,486,900

Clinical
Trials

572

Investments at Clinical Trial Sites

$347.6M

Clinical Trial Participants

15,666

Total Economic Impact of Clinical Trial Sites

$1B

bottom of page